Bionik Laboratories

(OTC) BNKL

Current Price$0.00

Market CapN/A

Since IPO (2015)-100%

5 Year-100%

1 Year+0%

1 Month-99%

Bionik Laboratories Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.81M

Net Income (TTM)

$5.07M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

928.54 (High)

Dividend

$0.00

Beta (Volatility)

928.54 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

928.54 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

BNKL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bionik Laboratories

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Richard Russo, Jr., CPA

Website

www.bioniklabs.com

Headquarters

Watertown, MA 02472, US

BNKL Financials

Key Financial Metrics (TTM)

Gross Margin

55%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

Return on Capital

-5%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

12.48M

Volume

Avg. Volume

Financials (TTM)

Gross Profit

$989.88K

Operating Income

$4.83M

EBITDA

$4.78M

Operating Cash Flow

$3.39M

Capital Expenditure

$8.69K

Free Cash Flow

$3.39M

Cash & ST Invst.

$427.38K

Total Debt

$2.41M

Bionik Laboratories Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2023YOY CHG

Revenue

$501.11K

+162.0%

Gross Profit

$254.12K

+91.6%

Gross Margin

50.71%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$1.42M

+29.6%

EBITDA

$1.28M

+11.2%

Quarterly Fundamentals

Name

Q4 2023YOY CHG

Net Cash

$1.98M

-199.7%

Accounts Receivable

$453.08K

+64.9%

Inventory

$1.03M

-13.1%

Long Term Debt

$2.39M

N/A

Short Term Debt

$22.07K

N/A

Return on Assets

-1.47%

N/A

Return on Invested Capital

-4.58%

N/A

Free Cash Flow

$757.70K

+45.1%

Operating Cash Flow

$756.94K

+45.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BGMDBG Medicine, Inc.

BGMDBG Medicine, Inc.$0.00+0.00%

OHAQOracle Healthcare Acquisition Corp.

OHAQOracle Healthcare Acquisition Corp.$0.00+0.00%

FSPMFusionPharm, Inc.

FSPMFusionPharm, Inc.$0.00+0.00%

BIMIBIMI International Medical Inc.

BIMIBIMI International Medical Inc.$0.00+0.00%

MILCMillennium Sustainable Ventures Corp.

MILCMillennium Sustainable Ventures Corp.$0.00+50.00%

CFRXQContraFect Corporation

CFRXQContraFect Corporation$0.00+0.00%

NMTRQ9 Meters Biopharma, Inc.

NMTRQ9 Meters Biopharma, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

DGXXDigi Power X

DGXXDigi Power X$5.11+0.29%

NOKNokia

NOKNokia$13.42+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.96-0.02%

CCLCarnival Corp.

CCLCarnival Corp.$25.77+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.81+0.02%

RIGTransocean

RIGTransocean$6.25-0.09%

CIFRCipher Mining

CIFRCipher Mining$22.10+0.24%

Questions About BNKL

What is the current price of Bionik Laboratories?

Bionik Laboratories is trading at N/A per share.

What is the 52-week range for Bionik Laboratories?

Over the past 52 weeks, Bionik Laboratories has traded between N/A and $0.00.

How much debt does Bionik Laboratories have?

As of the most recent reporting period, Bionik Laboratories reported total debt of $2.41M.

How much cash does Bionik Laboratories have on hand?

Bionik Laboratories reported $427,383 in cash and cash equivalents in its most recent financial results.

What is Bionik Laboratories’s dividend yield?

Bionik Laboratories does not currently have a dividend yield.

Bionik Laboratories

Bionik Laboratories Financials at a Glance

BNKL News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bionik Laboratories

BNKL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bionik Laboratories Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BNKL

What is the current price of Bionik Laboratories?

What is the 52-week range for Bionik Laboratories?

How much debt does Bionik Laboratories have?

How much cash does Bionik Laboratories have on hand?

What is Bionik Laboratories’s dividend yield?

Premium Investing Services